TransMedics Group, Inc. TMDX Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by TransMedics Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Cash.
The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about TransMedics Group, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TransMedics Group, Inc.'s cash & equivalents?
- TransMedics Group, Inc. (TMDX) reported cash & equivalents of $461.74M in Q1 2026.
- How has TransMedics Group, Inc.'s cash & equivalents changed year-over-year?
- TransMedics Group, Inc.'s cash & equivalents increased by 48.9% year-over-year, from $310.14M to $461.74M.
- What is the long-term trend for TransMedics Group, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), TransMedics Group, Inc.'s cash & equivalents has grown at a 81.8% compound annual growth rate (CAGR), from $24.58M to $488.37M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.